TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
Condition(s):Chronic Myeloid LeukemiaLast Updated:October 10, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Chronic Myeloid LeukemiaLast Updated:October 10, 2023Recruiting
Condition(s):Chronic Myeloid Leukemia, BCR/ABL-PositiveLast Updated:September 7, 2022Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:January 10, 2024Recruiting
Condition(s):Chronic Myelogenous Leukemia – Chronic PhaseLast Updated:November 30, 2023Recruiting
Condition(s):Chronic Myeloid LeukaemiaLast Updated:January 12, 2023Recruiting
Condition(s):CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE; CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISISLast Updated:August 7, 2020Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 26, 2024Recruiting
Condition(s):Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive; BCR-ABL1 Positive Chronic Myelogenous Leukemia; BCR-ABL1 PositiveLast Updated:October 27, 2023Recruiting
Condition(s):Chronic Myeloid Leukemia; Chronic Phase Chronic Myelogenous LeukemiaLast Updated:February 28, 2024Recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:October 5, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.